vs
Digimarc CORP（DMRC）与IMMUCELL CORP（ICCC）财务数据对比。点击上方公司名可切换其他公司
Digimarc CORP的季度营收约是IMMUCELL CORP的1.6倍（$8.9M vs $5.5M），IMMUCELL CORP净利率更高（-2.5% vs -47.2%，领先44.7%），Digimarc CORP同比增速更快（2.9% vs -8.4%），Digimarc CORP自由现金流更多（$895.0K vs $-1.8M），过去两年IMMUCELL CORP的营收复合增速更高（3.9% vs -5.3%）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
ImmuCell Corp是一家总部位于美国的动物健康生物技术企业，主要研发、生产和销售以奶牛为主的家畜相关保健与治疗产品，核心产品包括乳腺炎等常见牛类疾病的防治方案，主要服务北美地区的畜牧养殖户和兽医机构。
DMRC vs ICCC — 直观对比
营收规模更大
DMRC
是对方的1.6倍
$5.5M
营收增速更快
DMRC
高出11.3%
-8.4%
净利率更高
ICCC
高出44.7%
-47.2%
自由现金流更多
DMRC
多$2.7M
$-1.8M
两年增速更快
ICCC
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $5.5M |
| 净利润 | $-4.2M | $-139.7K |
| 毛利率 | 63.5% | 42.9% |
| 营业利润率 | -48.2% | 0.4% |
| 净利率 | -47.2% | -2.5% |
| 营收同比 | 2.9% | -8.4% |
| 净利润同比 | 51.4% | 80.1% |
| 每股收益（稀释后） | $-0.18 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCICCC
| Q4 25 | $8.9M | — | ||
| Q3 25 | $7.6M | $5.5M | ||
| Q2 25 | $8.0M | $6.4M | ||
| Q1 25 | $9.4M | $8.1M | ||
| Q4 24 | $8.7M | $7.8M | ||
| Q3 24 | $9.4M | $6.0M | ||
| Q2 24 | $10.4M | $5.5M | ||
| Q1 24 | $9.9M | $7.3M |
净利润DMRCICCC
| Q4 25 | $-4.2M | — | ||
| Q3 25 | $-8.2M | $-139.7K | ||
| Q2 25 | $-8.2M | $501.9K | ||
| Q1 25 | $-11.7M | $1.4M | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-10.8M | $-701.7K | ||
| Q2 24 | $-9.3M | $-1.5M | ||
| Q1 24 | $-10.3M | $-437.9K |
毛利率DMRCICCC
| Q4 25 | 63.5% | — | ||
| Q3 25 | 58.3% | 42.9% | ||
| Q2 25 | 58.8% | 43.7% | ||
| Q1 25 | 65.0% | 41.6% | ||
| Q4 24 | 60.8% | 36.5% | ||
| Q3 24 | 62.4% | 26.3% | ||
| Q2 24 | 66.1% | 22.5% | ||
| Q1 24 | 62.5% | 31.6% |
营业利润率DMRCICCC
| Q4 25 | -48.2% | — | ||
| Q3 25 | -109.7% | 0.4% | ||
| Q2 25 | -105.2% | 8.8% | ||
| Q1 25 | -128.9% | 13.9% | ||
| Q4 24 | -105.1% | 8.0% | ||
| Q3 24 | -120.4% | -9.6% | ||
| Q2 24 | -96.2% | -25.3% | ||
| Q1 24 | -109.2% | -4.1% |
净利率DMRCICCC
| Q4 25 | -47.2% | — | ||
| Q3 25 | -106.9% | -2.5% | ||
| Q2 25 | -102.6% | 7.8% | ||
| Q1 25 | -125.2% | 17.9% | ||
| Q4 24 | -99.9% | — | ||
| Q3 24 | -113.9% | -11.7% | ||
| Q2 24 | -89.3% | -28.0% | ||
| Q1 24 | -104.0% | -6.0% |
每股收益（稀释后）DMRCICCC
| Q4 25 | $-0.18 | — | ||
| Q3 25 | $-0.38 | $-0.02 | ||
| Q2 25 | $-0.38 | $0.06 | ||
| Q1 25 | $-0.55 | $0.16 | ||
| Q4 24 | $-0.40 | $0.09 | ||
| Q3 24 | $-0.50 | $-0.09 | ||
| Q2 24 | $-0.43 | $-0.20 | ||
| Q1 24 | $-0.50 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $3.9M |
| 总债务越低越好 | — | $9.5M |
| 股东权益账面价值 | $40.2M | $29.8M |
| 总资产 | $53.0M | $45.7M |
| 负债/权益比越低杠杆越低 | — | 0.32× |
8季度趋势，按日历期对齐
现金及短期投资DMRCICCC
| Q4 25 | $12.9M | — | ||
| Q3 25 | $12.6M | $3.9M | ||
| Q2 25 | $16.1M | — | ||
| Q1 25 | $21.6M | — | ||
| Q4 24 | $28.7M | $3.8M | ||
| Q3 24 | $33.7M | — | ||
| Q2 24 | $41.5M | $1.3M | ||
| Q1 24 | $48.9M | $960.3K |
总债务DMRCICCC
| Q4 25 | — | — | ||
| Q3 25 | — | $9.5M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $8.7M | ||
| Q4 24 | — | $9.0M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | $9.8M | ||
| Q1 24 | — | $10.2M |
股东权益DMRCICCC
| Q4 25 | $40.2M | — | ||
| Q3 25 | $41.4M | $29.8M | ||
| Q2 25 | $46.5M | $29.9M | ||
| Q1 25 | $50.0M | $29.0M | ||
| Q4 24 | $61.4M | $27.5M | ||
| Q3 24 | $70.2M | $26.4M | ||
| Q2 24 | $77.2M | $23.5M | ||
| Q1 24 | $84.5M | $24.6M |
总资产DMRCICCC
| Q4 25 | $53.0M | — | ||
| Q3 25 | $55.4M | $45.7M | ||
| Q2 25 | $60.7M | $46.7M | ||
| Q1 25 | $66.5M | $45.6M | ||
| Q4 24 | $75.8M | $45.1M | ||
| Q3 24 | $85.0M | $44.4M | ||
| Q2 24 | $93.4M | $41.9M | ||
| Q1 24 | $99.7M | $43.1M |
负债/权益比DMRCICCC
| Q4 25 | — | — | ||
| Q3 25 | — | 0.32× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | 0.33× | ||
| Q3 24 | — | 0.36× | ||
| Q2 24 | — | 0.42× | ||
| Q1 24 | — | 0.41× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | $-1.8M |
| 自由现金流率自由现金流/营收 | 10.0% | -32.3% |
| 资本支出强度资本支出/营收 | 1.1% | 10.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | $715.4K |
8季度趋势，按日历期对齐
经营现金流DMRCICCC
| Q4 25 | $991.0K | — | ||
| Q3 25 | $-2.6M | $-1.2M | ||
| Q2 25 | $-4.7M | $1.6M | ||
| Q1 25 | $-5.5M | $1.6M | ||
| Q4 24 | $-4.2M | $-3.1K | ||
| Q3 24 | $-7.1M | $-639.3K | ||
| Q2 24 | $-6.8M | $581.8K | ||
| Q1 24 | $-8.4M | $418.5K |
自由现金流DMRCICCC
| Q4 25 | $895.0K | — | ||
| Q3 25 | $-2.8M | $-1.8M | ||
| Q2 25 | $-4.9M | $1.4M | ||
| Q1 25 | $-5.5M | $1.2M | ||
| Q4 24 | $-4.2M | $-199.3K | ||
| Q3 24 | $-7.2M | $-727.7K | ||
| Q2 24 | $-6.9M | $471.0K | ||
| Q1 24 | $-8.5M | $348.1K |
自由现金流率DMRCICCC
| Q4 25 | 10.0% | — | ||
| Q3 25 | -36.9% | -32.3% | ||
| Q2 25 | -61.0% | 22.4% | ||
| Q1 25 | -59.1% | 15.4% | ||
| Q4 24 | -49.1% | -2.6% | ||
| Q3 24 | -75.7% | -12.1% | ||
| Q2 24 | -66.1% | 8.6% | ||
| Q1 24 | -85.8% | 4.8% |
资本支出强度DMRCICCC
| Q4 25 | 1.1% | — | ||
| Q3 25 | 2.9% | 10.8% | ||
| Q2 25 | 2.5% | 2.4% | ||
| Q1 25 | 0.6% | 4.1% | ||
| Q4 24 | 0.2% | 2.5% | ||
| Q3 24 | 0.7% | 1.5% | ||
| Q2 24 | 0.3% | 2.0% | ||
| Q1 24 | 1.1% | 1.0% |
现金转化率DMRCICCC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.19× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
ICCC
暂无分部数据
